pazopanib 200 MG Oral Tablet
- RxCUI
- 867502
- RxNorm name
- pazopanib 200 MG Oral Tablet
- Display name
- pazopanib 200 MG Oral Tablet
- Full name
- pazopanib 200 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:27
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pazopanib | PAZOPANIB | SUN PHARMACEUTICAL INDUSTRIES, INC. | d3e8dd09-d7d2-43da-8f63-bdf0ea0fcdf5 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 867502 |
| Pazopanib | PAZOPANIB | AvKARE | 16c5df52-0031-034d-e063-6294a90a1717 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 867502 |
| VOTRIENT | PAZOPANIB HYDROCHLORIDE | Novartis Pharmaceuticals Corporation | eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 867502 |
| Pazopanib | PAZOPANIB | Golden State Medical Supply, Inc. | 115eb5bb-1403-fb3d-e063-6394a90ad320 | 2025-11-24 | Boxed warning, Warnings, Adverse reactions | 867502 |
| Pazopanib | PAZOPANIB | Apotex Corp. | b05ea49a-a764-5ff2-6e4a-26add69da9e2 | 2025-09-22 | Boxed warning, Warnings, Adverse reactions | 867502 |
| Pazopanib | PAZOPANIB | Aurobindo Pharma Limited | 25575cc6-5757-4f9b-9c09-0c4deb61ba12 | 2024-12-05 | Boxed warning, Warnings, Adverse reactions | 867502 |
| pazopanib | PAZOPANIB HYDROCHLORIDE | Novugen Pharma (USA) LLC. | 25305d33-caa0-4577-8b7b-06e430c34c39 | 2024-08-19 | Boxed warning, Warnings, Adverse reactions | 867502 |
| Pazopanib | PAZOPANIB | Teva Pharmaceuticals, Inc. | 9f7ea520-a152-401e-b1f7-b5ef8c7a2239 | 2024-05-28 | Boxed warning, Warnings, Adverse reactions | 867502 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7 | pazopanib 200 MG Oral Tablet | SCD | 15 | These highlights do not include all the information needed to use VOTRIENT safely and effectively. See full prescribing information for VOTRIENT. VOTRIENT ® (pazopanib) tablets, for oral use Initial U.S. Approval: 2009 | 20251216 |
| eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7 | PAZOPanib 200 MG Oral Tablet | PSN | 15 | These highlights do not include all the information needed to use VOTRIENT safely and effectively. See full prescribing information for VOTRIENT. VOTRIENT ® (pazopanib) tablets, for oral use Initial U.S. Approval: 2009 | 20251216 |
| eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7 | pazopanib (as pazopanib hydrochloride) 200 MG Oral Tablet | SY | 15 | These highlights do not include all the information needed to use VOTRIENT safely and effectively. See full prescribing information for VOTRIENT. VOTRIENT ® (pazopanib) tablets, for oral use Initial U.S. Approval: 2009 | 20251216 |
| d3e8dd09-d7d2-43da-8f63-bdf0ea0fcdf5 | pazopanib 200 MG Oral Tablet | SCD | 4 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20260519 |
| d3e8dd09-d7d2-43da-8f63-bdf0ea0fcdf5 | PAZOPanib 200 MG Oral Tablet | PSN | 4 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20260519 |
| d3e8dd09-d7d2-43da-8f63-bdf0ea0fcdf5 | pazopanib (as pazopanib hydrochloride) 200 MG Oral Tablet | SY | 4 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20260519 |
| b05ea49a-a764-5ff2-6e4a-26add69da9e2 | pazopanib (as pazopanib hydrochloride) 200 MG Oral Tablet | SY | 4 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20250922 |
| b05ea49a-a764-5ff2-6e4a-26add69da9e2 | pazopanib 200 MG Oral Tablet | SCD | 4 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20250922 |
| b05ea49a-a764-5ff2-6e4a-26add69da9e2 | PAZOPanib 200 MG Oral Tablet | PSN | 4 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20250922 |
| 115eb5bb-1403-fb3d-e063-6394a90ad320 | pazopanib (as pazopanib hydrochloride) 200 MG Oral Tablet | SY | 3 | PAZOPANIB TABLETS. These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20251124 |
| 115eb5bb-1403-fb3d-e063-6394a90ad320 | pazopanib 200 MG Oral Tablet | SCD | 3 | PAZOPANIB TABLETS. These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20251124 |
| 115eb5bb-1403-fb3d-e063-6394a90ad320 | PAZOPanib 200 MG Oral Tablet | PSN | 3 | PAZOPANIB TABLETS. These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20251124 |
| 9f7ea520-a152-401e-b1f7-b5ef8c7a2239 | pazopanib 200 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20240528 |
| 9f7ea520-a152-401e-b1f7-b5ef8c7a2239 | pazopanib (as pazopanib hydrochloride) 200 MG Oral Tablet | SY | 3 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20240528 |
| 9f7ea520-a152-401e-b1f7-b5ef8c7a2239 | PAZOPanib 200 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20240528 |
| 16c5df52-0031-034d-e063-6294a90a1717 | pazopanib (as pazopanib hydrochloride) 200 MG Oral Tablet | SY | 2 | Pazopanib Tablets Rx only These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. Initial U.S. Approval: 2009 | 20260119 |
| 16c5df52-0031-034d-e063-6294a90a1717 | pazopanib 200 MG Oral Tablet | SCD | 2 | Pazopanib Tablets Rx only These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. Initial U.S. Approval: 2009 | 20260119 |
| 16c5df52-0031-034d-e063-6294a90a1717 | PAZOPanib 200 MG Oral Tablet | PSN | 2 | Pazopanib Tablets Rx only These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. Initial U.S. Approval: 2009 | 20260119 |
| 25305d33-caa0-4577-8b7b-06e430c34c39 | PAZOPanib 200 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20240819 |
| 25305d33-caa0-4577-8b7b-06e430c34c39 | pazopanib 200 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20240819 |
| 25305d33-caa0-4577-8b7b-06e430c34c39 | pazopanib (as pazopanib hydrochloride) 200 MG Oral Tablet | SY | 2 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20240819 |
| 25575cc6-5757-4f9b-9c09-0c4deb61ba12 | pazopanib 200 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20241205 |
| 25575cc6-5757-4f9b-9c09-0c4deb61ba12 | PAZOPanib 200 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20241205 |
| 25575cc6-5757-4f9b-9c09-0c4deb61ba12 | pazopanib (as pazopanib hydrochloride) 200 MG Oral Tablet | SY | 1 | These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009 | 20241205 |